Pioglitazone to Prevent Vascular Events - IRIS Study Reviewed
Darren McGuire | Cardiovascular effects of diabetes medications: Lessons learned from CVOTs
Reversing Arterial Plaque with Metformin & Pioglitazone
IRIS: Pioglitazone Reduced the Risk of Recurrent Stroke and MI for Study Patients
Pioglitazone Improves Insulin Sensitivity and Prevents Ischemic Stroke
Response to Pioglitazone in Patients With Nonalcoholic Steatohepatitis With vs...
Response to Pioglitazone in Patients With Nonalcoholic Steatohepatitis With vs ....
Prediabetes: Making a Diagnosis and Selecting a Treatment Approach
Actos: Side effects, dosage, uses, and more
Diabetes, the New Epidemic - Dr Paolo Pozzilli
Professor Stephen Wiviott - 'SGLT2 Outcome trials - an evolving story'
Dr. Kenneth Cusi - The Good and the Bad of Pioglitazone | IDEC 2019
Diabetes & Heart Disease: Medications for Type 2 Diabetes
Clinical Updates on Pioglitazone with latest recommendations from ADA 2022
How to Prevent Heart Attack and Stroke with METFORMIN (Part 2 in a Series)
Diabetes Medication - Pioglitazone or Actos
Dr Shalini Jaggi - What is the role of Pioglitazone in the era of newer agents?
Pioglitazone
ADA 2018: Clinically Relevant Data on Pioglitazone and CV Risk Reduction
Pros and cons of antidiabetic drugs
